Grace Medtrade Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 30-07-2024
- Paid Up Capital ₹ 2.93 M
as on 30-07-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.10 Cr
as on 30-07-2024
- Satisfied Charges ₹ 6.50 M
as on 30-07-2024
- Revenue 27.63%
(FY 2023)
- Profit -1478.58%
(FY 2023)
- Ebitda -144.50%
(FY 2023)
- Net Worth -5.81%
(FY 2023)
- Total Assets 26.25%
(FY 2023)
About Grace Medtrade
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.93 M.
The company currently has active open charges totaling ₹5.10 Cr. The company has closed loans amounting to ₹6.50 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Kapoor and Megha Khannah serve as directors at the Company.
- CIN/LLPIN
U33111DL2010PTC199609
- Company No.
199609
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Grace Medtrade?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Megha Khannah  | Director | 01-Sep-2010 | Current |
| Deepak Kapoor | Director | 30-Jul-2021 | Current |
Financial Performance of Grace Medtrade.
Grace Medtrade Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.63% increase. The company also saw a substantial fall in profitability, with a 1478.58% decrease in profit. The company's net worth dipped by a decrease of 5.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grace Medtrade?
In 2023, Grace Medtrade had a promoter holding of 98.29% and a public holding of 1.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹5.10 Cr
₹0.65 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 2.00 Cr
- Ing Vysya Bank Limited : 1.60 Cr
- Standard Chartered Bank : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 2019 | State Bank Of India | ₹2.00 Cr | Open |
| 15 Oct 2012 | Ing Vysya Bank Limited | ₹1.60 Cr | Open |
| 01 Jul 2010 | Standard Chartered Bank | ₹1.50 Cr | Open |
| 15 May 2012 | Canara Bank | ₹6.50 M | Satisfied |
How Many Employees Work at Grace Medtrade?
Unlock and access historical data on people associated with Grace Medtrade, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grace Medtrade, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grace Medtrade's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
